| Filed | Form | Description | |
|---|---|---|---|
| 8/11/25 | DEF 14A | DEF 14A | → |
| 8/1/25 | PRE 14A | PRE 14A | → |
| 7/24/25 | DEFA14A | DEFA14A | → |
| 7/22/25 | DEFA14A | DEFA14A | → |
| 4/26/24 | DEFA14A | DEFA14A | → |
| 4/26/24 | DEF 14A | DEF 14A | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 7/17/25 | 3 | 3 | → |
| 4/3/25 | 4 | 4 | → |
| 4/3/25 | 4 | 4 | → |
| 4/3/25 | 4 | 4 | → |
| 3/31/25 | 4 | 4 | → |
| 3/31/25 | 4 | 4 | → |
| ↓ | |||
Unity Biotechnology, Inc. was a publicly traded American biotechnology company that develops drugs that target senescent cells.